Fig. 4. Expression of MAP-2 in the medulla oblongata of the control, melatonin, CYP, CYP/melatonin groups at 7 and 21 PNDs. CYP administration dramatically decreased the expression of MAP-2 in rat medulla oblongata compared to the control group. Melatonin co-treatment significantly upregulated the expression of MAP-2. CYP, cypermethrin; MAP-2, microtubule-associated protein-2; PND, postnatal day. Scale bar=20 µm.
© Anat Cell Biol